糠酸莫米松鼻喷雾剂的特点及其在过敏性鼻炎管理中的应用。
Features of mometasone furoate nasal spray and its utility in the management of allergic rhinitis.
作者信息
Schenkel Eric
机构信息
Valley Allergy and Asthma Treatment Center/Valley Clinical Research Center, Easton, PA, USA.
出版信息
Expert Opin Pharmacother. 2003 Sep;4(9):1579-91. doi: 10.1517/14656566.4.9.1579.
Mometasone furoate aqueous nasal spray (NS; Nasonex, Schering Corporation), is a synthetic corticosteroid approved for the prophylaxis and treatment of seasonal allergic rhinitis (SAR) and the treatment of perennial allergic rhinitis (PAR) in patients >or= 12 years of age, and for the treatment of SAR and PAR in children as young as 2 years of age. Studies demonstrate that mometasone furoate NS is a potent, clinically effective and well-tolerated intranasal corticosteroid with negligible systemic activity and which offers the convenience of once-daily dosing.
糠酸莫米松水鼻喷雾剂（NS；内舒拿，先灵葆雅公司）是一种合成皮质类固醇，已被批准用于预防和治疗季节性变应性鼻炎（SAR）以及治疗12岁及以上患者的常年性变应性鼻炎（PAR），还可用于治疗2岁及以上儿童的SAR和PAR。研究表明，糠酸莫米松水鼻喷雾剂是一种强效、临床有效的鼻内皮质类固醇，耐受性良好，全身活性可忽略不计，且具有每日一次给药的便利性。
Zotero 插件